These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9883747)

  • 1. Endothelial dysfunction in hypertension: fact or fancy?
    Taddei S; Virdis A; Ghiadoni L; Salvetti A
    J Cardiovasc Pharmacol; 1998; 32 Suppl 3():S41-7. PubMed ID: 9883747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial dysfunction in hypertension.
    Taddei S; Virdis A; Ghiadoni L; Salvetti G; Salvetti A
    J Nephrol; 2000; 13(3):205-10. PubMed ID: 10928297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial dysfunction in hypertension.
    Taddei S; Virdis A; Ghiadoni L; Sudano I; Salvetti A
    J Cardiovasc Pharmacol; 2001 Nov; 38 Suppl 2():S11-4. PubMed ID: 11811368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary endothelial dysfunction: hypertension and heart failure.
    Boulanger CM
    J Mol Cell Cardiol; 1999 Jan; 31(1):39-49. PubMed ID: 10072714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Endothelial function and arterial hypertension].
    Taddei S; Virdis A; Ghiadoni L; Salvetti A
    Ann Ital Med Int; 1995 Oct; 10 Suppl():85S-90S. PubMed ID: 8562274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of endothelium in human hypertension.
    Taddei S; Virdis A; Ghiadoni L; Salvetti A
    Curr Opin Nephrol Hypertens; 1998 Mar; 7(2):203-9. PubMed ID: 9529624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelium, atherosclerosis and calcium channel blockers.
    Biswas TK
    J Indian Med Assoc; 2003 Jul; 101(7):428-31. PubMed ID: 14748381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial dysfunction in essential hypertension.
    Panza JA
    Clin Cardiol; 1997 Nov; 20(11 Suppl 2):II-26-33. PubMed ID: 9422849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rationale for treatment of endothelial dysfunction in hypertension.
    Ruschitzka F; Corti R; Noll G; Lüscher TF
    J Hypertens Suppl; 1999 Feb; 17(1):S25-35. PubMed ID: 10340841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting endothelial dysfunction in hypertensive subjects.
    Thuillez C; Richard V
    J Hum Hypertens; 2005 Jun; 19 Suppl 1():S21-5. PubMed ID: 16075029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial dysfunction and oxidative stress in arterial hypertension.
    Ferroni P; Basili S; Paoletti V; Davì G
    Nutr Metab Cardiovasc Dis; 2006 Apr; 16(3):222-33. PubMed ID: 16580590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of prognostic role of endothelial dysfunction in subcutaneous small resistance arteries of hypertensive patients.
    Rizzoni D; Porteri E; De Ciuceis C; Boari GE; Zani F; Miclini M; Paiardi S; Tiberio GA; Giulini SM; Muiesan ML; Castellano M; Rosei EA
    J Hypertens; 2006 May; 24(5):867-73. PubMed ID: 16612248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial function and hypertension.
    Landmesser U; Drexler H
    Curr Opin Cardiol; 2007 Jul; 22(4):316-20. PubMed ID: 17556884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Participation of endothelium-derived vasoconstrictor factors in arterial hypertension].
    Lahera V; Navarro-Cid J; Maeso R; Cachofeiro V
    Rev Esp Cardiol; 1999; 52 Suppl 3():4-11. PubMed ID: 10614144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial dysfunction in hypertension. A critical evaluation.
    Van Zwieten PA
    Blood Press Suppl; 1997; 2():67-70. PubMed ID: 9495630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of sulfhydryl and non-sulfhydryl angiotensin-converting enzyme inhibitors on endothelial function in essential hypertensive patients.
    Pasini AF; Garbin U; Nava MC; Stranieri C; Pellegrini M; Boccioletti V; Luchetta ML; Fabrizzi P; Lo Cascio V; Cominacini L
    Am J Hypertens; 2007 Apr; 20(4):443-50. PubMed ID: 17386354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial dysfunction in diabetes mellitus.
    Cosentino F; Lüscher TF
    J Cardiovasc Pharmacol; 1998; 32 Suppl 3():S54-61. PubMed ID: 9883749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired endothelial nitric oxide bioavailability: a common link between aging, hypertension, and atherogenesis?
    Walsh T; Donnelly T; Lyons D
    J Am Geriatr Soc; 2009 Jan; 57(1):140-5. PubMed ID: 19054194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between nitric oxide and angiotensin II in the endothelium: role in atherosclerosis and hypertension.
    Schulman IH; Zhou MS; Raij L
    J Hypertens Suppl; 2006 Mar; 24(1):S45-50. PubMed ID: 16601573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of endothelial dysfunction in the pathogenesis and in clinical practice of atherosclerosis. Current evidences].
    Patti G; Melfi R; Di Sciascio G
    Recenti Prog Med; 2005 Oct; 96(10):499-507. PubMed ID: 16491775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.